JP2023520770A5 - - Google Patents
Info
- Publication number
- JP2023520770A5 JP2023520770A5 JP2022558131A JP2022558131A JP2023520770A5 JP 2023520770 A5 JP2023520770 A5 JP 2023520770A5 JP 2022558131 A JP2022558131 A JP 2022558131A JP 2022558131 A JP2022558131 A JP 2022558131A JP 2023520770 A5 JP2023520770 A5 JP 2023520770A5
- Authority
- JP
- Japan
- Prior art keywords
- dose
- serum
- level
- deposition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000939P | 2020-03-27 | 2020-03-27 | |
| US63/000,939 | 2020-03-27 | ||
| PCT/US2021/024345 WO2021195488A1 (en) | 2020-03-27 | 2021-03-26 | Compositions and methods for treating pulmonary edema or lung inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023520770A JP2023520770A (ja) | 2023-05-19 |
| JP2023520770A5 true JP2023520770A5 (https=) | 2024-06-24 |
Family
ID=77892642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558131A Pending JP2023520770A (ja) | 2020-03-27 | 2021-03-26 | 肺浮腫又は肺炎症を治療するための組成物及び方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12569459B2 (https=) |
| EP (1) | EP4126104A4 (https=) |
| JP (1) | JP2023520770A (https=) |
| CN (1) | CN115551569A (https=) |
| CA (1) | CA3177377A1 (https=) |
| MX (1) | MX2022011821A (https=) |
| WO (1) | WO2021195488A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025024778A1 (en) * | 2023-07-27 | 2025-01-30 | Regents Of The University Of Minnesota | Medical treatment system and methods |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716877B2 (en) | 2001-01-31 | 2004-04-06 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Method to treat chronic heart failure and/or elevated cholesterol levels |
| US8668926B1 (en) | 2003-09-15 | 2014-03-11 | Shaker A. Mousa | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
| CA2578709C (en) | 2004-06-17 | 2010-06-15 | Virun, Inc. | Compositions comprising a mucoadhesive protein and an active principle for mucosal delivery of said agents |
| US9220788B2 (en) * | 2009-06-17 | 2015-12-29 | Nanopharmaceuticals Llc | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof |
| US20090022806A1 (en) | 2006-12-22 | 2009-01-22 | Mousa Shaker A | Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists and formulations and uses thereof |
| US8309080B2 (en) | 2007-12-06 | 2012-11-13 | Naidu Lp | Metallo-protein and tocotrienol (MP-T3) compositions and uses thereof |
| US8304401B2 (en) | 2008-09-02 | 2012-11-06 | Trustees Of Dartmouth College | Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels |
| WO2010124372A1 (en) * | 2009-04-29 | 2010-11-04 | Genomedx Biosciences, Inc. | Systems and methods for expression-based classification of thyroid tissue |
| PT2501413T (pt) | 2009-11-18 | 2019-07-10 | Nektar Therapeutics | Formas de sal de ácido de conjugados de polímero-fármaco |
| EP3119768B1 (en) | 2014-03-16 | 2019-07-31 | Hadasit Medical Research Services And Development Ltd. | 3,4-bromo or -sulfonate substituted 1h-pyrrole-2,5-dione derivatives as type iii deiodinase (dio3) inhibitors for treating depressions and cancer |
| US9913819B2 (en) | 2014-06-12 | 2018-03-13 | Yale University | Methods of treating or preventing fibrotic lung diseases |
| CN107041879A (zh) | 2017-04-01 | 2017-08-15 | 深圳市润佳通科技有限公司 | 甲状腺激素及其药学上可接受的盐或前药在制备治疗和/或预防肺部疾病的药物中的应用 |
| MX2020007971A (es) | 2018-01-31 | 2020-09-09 | Univ Minnesota | Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar. |
| WO2019178023A1 (en) | 2018-03-12 | 2019-09-19 | Yale University | Methods of Treating or Preventing Acute Respiratory Distress Syndrome |
-
2021
- 2021-03-26 EP EP21776008.1A patent/EP4126104A4/en active Pending
- 2021-03-26 US US17/914,942 patent/US12569459B2/en active Active
- 2021-03-26 CA CA3177377A patent/CA3177377A1/en active Pending
- 2021-03-26 JP JP2022558131A patent/JP2023520770A/ja active Pending
- 2021-03-26 WO PCT/US2021/024345 patent/WO2021195488A1/en not_active Ceased
- 2021-03-26 CN CN202180038002.8A patent/CN115551569A/zh active Pending
- 2021-03-26 MX MX2022011821A patent/MX2022011821A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zoltowska et al. | The interleukin‐33 receptor ST 2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma | |
| HRP20150290T1 (hr) | Metoda lijeäśenja karcinoma prostate s gnrh antagonistom degareliksom | |
| Tharakan et al. | Reversal of cigarette smoke extract‐induced sinonasal epithelial cell barrier dysfunction through Nrf2 activation | |
| JP2014503593A5 (https=) | ||
| JP2023520770A5 (https=) | ||
| JP2018505183A5 (https=) | ||
| RU2008141218A (ru) | Способ дифференциальной диагностики инфильтративного туберкулеза и периферического рака легких | |
| Kumar et al. | A Comparative study of the clinical characteristics of the first and second waves of COVID-19 in a tertiary care centre of North India | |
| Carfagna et al. | Occurrence of influenza A (H1N1) v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. | |
| Duran et al. | The effect of zinc supplementation on cigarette smoke-induced nephrotoxicity in rats | |
| Lai et al. | Comparison of nebulized budesonide with intravenous dexamethasone in the treatment of young children hospitalized with acute asthma | |
| Yao et al. | C68 IMMUNE CELL INTERACTIONS IN COPD: Increased Neutrophil Gelatinase-Associated Lipocalin (ngal) Promotes Airway Remodeling In COPD | |
| Ohara | Fatal acute exacerbation of idiopathic pulmonary fibrosis: case report | |
| Li et al. | Cluster analysis of chronic obstructive pulmonary disease (COPD) related phenotypes in the SubPopulations And InteRmediate Outcome Measures In COPD Study (SPIROMICS) | |
| CHEN et al. | Effects of inhaled nitric oxide on intrapulmonarynitric oxide production and expression of plasminogen activator inhibitor-1 in lipopolysaccharide-induced acute lung injury | |
| CAO et al. | Expression of Gq in bronchopulmonary tissues in rats after inhalation of cigarette smoke | |
| Zhang et al. | The Iron Chelator, DIBI, Reduces Bacterial Load and Inflammation in Experimental Lung Infection | |
| Asakura et al. | S1p Receptor Modulation Expands Cd11b+ gr-1+ Cells And Inhibits Lymphocyte Infiltration In The Lungs And Ameliorate Murine Pulmonary Emphysema | |
| Bayat et al. | High Resolution CT in Children with Cystic Fibrosis: Correlation between Lung Attenuation, Radiological Score and Respiratory Function. | |
| Lee et al. | Toxicogenomic study of PHMG-induced pulmonary toxicity in rats | |
| Liu et al. | The Deletion Of Cxcr3 Gene Can't Prevent From COPD After Long Term Of Cigarette Smoking Exposure In Mice | |
| Romberger et al. | Inhibition Of EGF Receptor Signaling Decreases Agricultural Dust-Mediated Lung Inflammatory Responses In Vivo And In Vitro | |
| Chang et al. | A77 CHANGES IN THE LUNG DUE TO DIETARY AND ENVIRONMENTAL EXPOSURES: Increased Airway Narrowing Capacity Of Bronchial Segments From Preterm Lambs In An Ovine Model Of Chorioamnionitis | |
| 이정대 et al. | ¹H-NMR-based toxicometabolomics study of PHMG-p-induced pulmonary damage in mice | |
| Koumoundouros et al. | Increased baseline airway resistance and smooth muscle content in sheep exposed to repeated challenges of house dust mite |